 |
Updated 6 September 2005
Back
to Main APP Directory
View APP Mutations
Diagram
by John Hardy, National Institute on Aging, Bethesda, MD, and Richard Crook, MD., Mayo Clinic, Jacksonville, FL.
Disease-associated Intra-A#&946; Mutations (Courtesy of Dominic Walsh)
| Mutation |
Phenotype |
Age of Onset |
References |
| Glu665Asp |
AD, but may not be pathogenic. |
86? |
Peacock
et al., 1994 |
| Lys/Met670/Asn/Leu (Swedish) |
AD |
52 (44-59) |
Mullan
et al., 1992 |
| Ala673Thr |
Normal |
N/A |
Peacock
et al., 1993 |
| His677Arg |
AD |
55 (55-56) |
Janssen et al., 2003 |
| D678N |
FAD |
60 |
Wakutani et al., 2004 |
| Ala692Gly (Flemish) |
Large dense core
plaques linked to CAA. |
40-60, but variable. |
Kumar-Singh et al., 2002 Hendriks
et al., 1992
Cras
et al., 1998
Roks et al., 2000 |
| Glu693Gly (Artic) |
AD, but may not be pathogenic. Reproduced plasma Aβ40 and 42, high protfibril levels. | 58? N/A
| Kamino
et al., 1992 Nilsbeth et al., 2001
|
| Glu693Gln (Dutch) |
HCHWA-D (a stroke syndrome). |
Typically ~50, but variable. |
Van Broeckhoven et al., 1990 |
| Glu693Lys (Italian) |
Cerebral hemorrhage. |
? |
Tagliavini et al., 1999 (no abstract available) |
| Asp694Asn (Iowa) |
AD or Cerebral hemorrhage. |
69 |
Grabowski et al., 2001 |
| Ala713Thr |
AD, but may not be pathogenic. |
59 |
Carter et al., 1992 |
| Ala713Val |
Schizophrenia, probably not pathogenic. |
? |
Jones
et al., 1992 |
| Thr714Ile (Austrian) |
Affects γ-secretase cleavage directly, 11X increase in Aβ42/Aβ40 ratio in vitro. In brain, abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated Aβ42 in complete absence of Aβ40. |
|
Kumar-Singh et al., 2000 |
| Thr714Ala (Iranian) |
AD |
52 (40-60) |
Pasaler et al., 2002 |
| Val715Met (French) |
AD |
52 (40-60) |
Ancolio
et al., 1999 |
| Val715Ala (German) |
AD |
47 |
De Jonghe et al., 2001; Cruts et al., 2003 |
| Ile716Val (Florida) |
AD |
55 |
Eckman
et al., 1997 |
| Ile716Thr |
AD |
55 |
Terrini et al.,
2002 |
| Val717Phe (Indiana) |
AD |
47 (42-52) |
Murrell
et al., 1991 |
| Val717Gly |
AD |
55 (45-62) |
Chartier-Harlin
et al., 1991 |
| Val717Ile (London) |
AD |
55 (50-60) |
Goate
et al., 1991 |
| Val717Leu |
CSF tau and A-β consistent with AD; earlier onset than other 717 mutations. |
38 |
Murrell et al., 2000 |
| Leu723Pro (Australian) |
AD |
56 (45-60) |
Kwok, 2000 |
Mutations in APP, PS1, and PS2 are also listed in the Alzheimer
Disease Mutation Database (ADMD), maintained by Marc Cruts.
|
 |